Combined antiretroviral therapy is effective on blood plasma hiv-1-rna: What about semen hiv-1-rna levels?

AIDS

Volumn 24, Issue 2, 2010, Pages 309-311

  Ghosn, Jade ^a,b   Chaix, Marie Laure ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; TENOFOVIR; VIRUS RNA;

BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MALE GENITAL SYSTEM; MALE HOMOSEXUAL; NOTE; PLASMA; PRIORITY JOURNAL; RNA ANALYSIS; SEMEN ANALYSIS; SEMINAL PLASMA; SEXUAL TRANSMISSION; THERAPY EFFECT; VIRUS LOAD; VIRUS SHEDDING; VIRUS TRANSMISSION;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; RNA, VIRAL; SEMEN; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 74249117656     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283323504     Document Type: Note

References (19)

1. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997; 146:350-357.
2. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999; 150:306-311.
3. Quinn TC, Wawer MJ, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
4. Vernazza P, Hirschel B, Bernasconi E, Flepp M. HIV-infected people free of other STDs are sexually not infectious on ̈ effective antiretroviral therapy. Schweizerische Arztezeitung 2008; 89:165-169.
5. Wilson DP. Data are lacking for quantifying HIV transmission risk in the presence of effective antiretroviral therapy. AIDS 2009; 23:1431-1433.
6. Sheth P, Kovacs C, Kemal K, Jones R, Raboud J, Pilon R, et al. Persistent HIV RNA shedding in semen despite effective anti-retroviral therapy. AIDS 2009; 23:2050-2054.
7. Marcelin AG, Tubiana R, Lambert-Niclot S, Lefebvre G, Dom-inguez S, Bonmarchand M, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetect-able HIV-1 RNA in blood plasma. AIDS 2008; 22:1677-1679.
8. Kalichman SC, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sex Transm Dis 2008; 35:55-60.
9. Munch J, Rucker E, Standker L, Adermann K, Goffinet C, Schindler M, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007; 131:1059-1071.
10. Ghosn J, Chaix ML, Peytavin G, Rey E, Bresson JL, Goujard C, et al. Penetration of enfuvirtide, tenofovir, efavirenz, and protease inhibitors in the genital tract of HIV-1-infected men. AIDS 2004; 18:1958-1961.
11. Vernazza P, DaneelS, Schiffer V, DecosterdL, Fierz W, Klimkait T, et al. The role of compartment penetration in PI-monother-apy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial. AIDS 2007; 21:1309-1315.
12. Ghosn J, Chaix ML, Peytavin G, Bresson JL, Galimand J, Girard PM, et al. Absence of HIV-1 shedding in male genital tract after 1 year of first-line lopinavir/ritonavir alone or in combination with zidovudine/lamivudine. J Antimicrob Chemother 2008; 61:1344-1347.
13. Ghosn J, Viard JP, Katlama C, de Almeida M, Tubiana R, Letourneur F, et al. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pretreated HIV-infected men. AIDS 2004; 18: 447-457.
14. Taylor S, Cane P, Hue S, Xu L, Wrin T, Lie Y, et al. Identification of a transmission chain of HIV type 1 containing drug resistance-associated mutations. AIDS Res Hum Retroviruses 2003; 19:353-361.
15. Ghosn J, Pellegrin I, Goujard C, Deveau C, Viard JP, Galimand J, et al. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time. AIDS 2006; 20:159-170.
16. Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, et al. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis 2007; 196:356-360.
17. Attia S, Egger M, Muller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009; 23:1397-1404.
18. Wilson DP, Law MG, Grulich AE, Cooper DA, Kaldor JM. Relation between HIV viral load and infectiousness: a model-based analysis. Lancet 2008; 372:314-320.
19. Bezemer D, de Wolf F, Boerlijst MC, van Sighem A, Hollings-worth TD, Prins M, et al. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy. AIDS 2008; 22:1071-1077.